TOR2A antibody (AA 194-221)
Quick Overview for TOR2A antibody (AA 194-221) (ABIN3029188)
Target
See all TOR2A AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 194-221
-
Purpose
- TOR2A Antibody
-
Cross-Reactivity (Details)
- Expected species reactivity: Rat
-
Purification
- Antigen affinity
-
Immunogen
- A portion of amino acids 194-221 from the human protein was used as the immunogen for this TOR2A antibody.
-
Isotype
- Ig Fraction
-
-
-
-
Application Notes
- Titration of the TOR2A antibody may be required due to differences in protocols and secondary/substrate sensitivity.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- In 1X PBS, pH 7.4, with 0.09 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Aliquot the TOR2A antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- TOR2A (Torsin Family 2, Member A (TOR2A))
-
Alternative Name
- TOR2A
-
Background
- Salusins are multifunctional bioactive peptides discovered by bioinformatics analyses of a full-length cDNA library. Salusin alpha and salusin beta are related peptides of 28 and 20 amino acids that were recently characterized. These peptides are considered to be biosynthesized from preprosalusin, an alternative-splicing product of the torsion dystonia-related gene (TOR2A), after frameshift reading and digestion at dibasic amino acids. Salusin alpha has recently been shown to be involved in atherosclerosis, it potently suppresses acyl-CoA:cholesterol acyltransferase-1 which stores cholesterol ester converted from free cholesterol in macrophages, thereby reducing human macrophage foam cell formation.
-
UniProt
- Q5JU69
Target
-